These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Wei JT; Dunn RL; Litwin MS; Sandler HM; Sanda MG Urology; 2000 Dec; 56(6):899-905. PubMed ID: 11113727 [TBL] [Abstract][Full Text] [Related]
4. Small bowel toxicity in pelvic radiotherapy for postoperative gynecological cancer: comparison between conformal radiotherapy and intensity modulated radiotherapy. Ray A; Sarkar B Asia Pac J Clin Oncol; 2013 Sep; 9(3):280-4. PubMed ID: 23279854 [TBL] [Abstract][Full Text] [Related]
6. Prospective phase-II-study evaluating postoperative radiotherapy of cervical and endometrial cancer patients using protons - the APROVE-trial. Arians N; Lindel K; Krisam J; Herfarth K; Krug D; Akbaba S; Oelmann-Avendano J; Debus J Radiat Oncol; 2017 Nov; 12(1):188. PubMed ID: 29179751 [TBL] [Abstract][Full Text] [Related]
7. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor]. Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688 [No Abstract] [Full Text] [Related]
8. Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years. Barocas DA; Alvarez J; Resnick MJ; Koyama T; Hoffman KE; Tyson MD; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF JAMA; 2017 Mar; 317(11):1126-1140. PubMed ID: 28324093 [TBL] [Abstract][Full Text] [Related]
9. Initial Report of Pencil Beam Scanning Proton Therapy for Posthysterectomy Patients With Gynecologic Cancer. Lin LL; Kirk M; Scholey J; Taku N; Kiely JB; White B; Both S Int J Radiat Oncol Biol Phys; 2016 May; 95(1):181-189. PubMed ID: 26372435 [TBL] [Abstract][Full Text] [Related]
10. Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design? Woo JA; Chen LN; Wang H; Cyr RA; Bhattasali O; Kim JS; Moures R; Yung TM; Lei S; Collins BT; Suy S; Dritschilo A; Lynch JH; Collins SP Front Oncol; 2015; 5():77. PubMed ID: 25874188 [TBL] [Abstract][Full Text] [Related]
12. Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life. Kupelian PA; Reddy CA; Klein EA; Willoughby TR Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):988-93. PubMed ID: 11704322 [TBL] [Abstract][Full Text] [Related]
13. An observational study evaluating the impact on prostate patient outcomes and experiences when radiation therapists use a standard grading system tool to assess and document treatment-related toxicities and interventions. Leung E; Fineberg H; Larsen T; Yaver M; Foo A; Ma J; Versloot J; Minotti SC J Med Imaging Radiat Sci; 2022 Sep; 53(3):444-452. PubMed ID: 35850922 [TBL] [Abstract][Full Text] [Related]
14. Pelvic insufficiency fractures in patients with cervical and endometrial cancer treated with postoperative pelvic radiation. Shih KK; Folkert MR; Kollmeier MA; Abu-Rustum NR; Sonoda Y; Leitao MM; Barakat RR; Alektiar KM Gynecol Oncol; 2013 Mar; 128(3):540-3. PubMed ID: 23262211 [TBL] [Abstract][Full Text] [Related]
15. Toxicity of Pelvic Lymph Node Irradiation With Intensity Modulated Radiation Therapy for High-Risk and Locally Advanced Prostate Cancer: A National Population-Based Study Using Patient-Reported Outcomes. Parry MG; Nossiter J; Cowling TE; Sujenthiran A; Berry B; Cathcart P; Clarke NW; Payne H; van der Meulen J; Aggarwal A Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1196-1203. PubMed ID: 32717261 [TBL] [Abstract][Full Text] [Related]
17. Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients. Anota A; Mariet AS; Maingon P; Joly F; Bosset JF; Guizard AV; Bittard H; Velten M; Mercier M Health Qual Life Outcomes; 2016 Dec; 14(1):168. PubMed ID: 27923377 [TBL] [Abstract][Full Text] [Related]
18. Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancer. Bai M; Gergelis KR; Sir M; Whitaker TJ; Routman DM; Stish BJ; Davis BJ; Pisansky TM; Choo R Cancer Med; 2020 Nov; 9(21):7925-7934. PubMed ID: 32931662 [TBL] [Abstract][Full Text] [Related]
19. Cross validation of the prostate cancer radiotherapy late toxicity (PCRT) questionnaire with the expanded prostate cancer index composite (EPIC) instrument. Rodrigues G; Bauman G; Venkatesan V; Ahmad B; Lock M; Sexton T; D'Souza D; Stitt L; Eid S Can J Urol; 2011 Aug; 18(4):5802-10. PubMed ID: 21854712 [TBL] [Abstract][Full Text] [Related]
20. Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers. Chen LA; Kim J; Boucher K; Terakedis B; Williams B; Nickman NA; Gaffney DK Gynecol Oncol; 2015 Mar; 136(3):521-8. PubMed ID: 25562668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]